Phage Display of Random Peptide Libraries: Applications, Limits, and Potential

Journal of Receptors and Signal Transduction

Volumn 23, Issue 4, 2003, Pages 307-349

  Szardenings, Michael ^a  

^a TECHNICAL UNIVERSITY OF BRAUNSCHWEIG   (Germany)

Author keywords

Enzyme inhibitor; Phage display; Random peptide library; Receptor ligand

Indexed keywords

ALPHA BUNGAROTOXIN; ANGIOTENSIN ANTIBODY; APOPTOSIS INHIBITOR; BIOTIN; CALMODULIN; COMPLEMENT COMPONENT C3B; CONCANAVALIN A; ENZYME INHIBITOR; FERRITIN ANTIBODY; IMMUNOGLOBULIN E ANTIBODY; INTERLEUKIN 1 ANTIBODY; LIGAND; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 2925; MONOCLONAL ANTIBODY AB192; PEPTIDE LIBRARY; POLYCLONAL ANTIBODY; SERUM ALBUMIN; UNCLASSIFIED DRUG; VINCULIN;

ANTIBODY DETECTION; BINDING AFFINITY; DRUG ACTIVITY; HUMAN; NONHUMAN; PEPTIDE ANALYSIS; PHAGE DISPLAY; PUBLICATION; RANDOMIZATION; REVIEW;

ANIMALS; ANTIBODIES; ANTIBODIES, MONOCLONAL; BACTERIOPHAGE M13; BACTERIOPHAGES; ENZYME INHIBITORS; GENE LIBRARY; HUMANS; LIGANDS; MODELS, GENETIC; PEPTIDE LIBRARY; TIME FACTORS;

EID: 0347623280     PISSN: 10799893     EISSN: 15324281     Source Type: Journal    
DOI: 10.1081/RRS-120026973     Document Type: Review

References (212)

1. Katz BA. Structural and mechanistic determinants of affinity and specificity of ligands discovered or engineered by phage display. Annu Rev Biophys Biomol Struct 1997; 26:27-45.
2. Smith GP. Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface. Science 1985; 228:1315-1317.
3. Parmley SF, Smith GP. Antibody-selectable filamentous fd phage vectors: affinity purification of target genes. Gene 1988; 73:305-318.
4. Scott JK, Smith GP. Searching for peptide ligands with an epitope library. Science 1990; 249:386-390.
5. Devlin JJ, Panganiban LC, Devlin PE. Random peptide libraries: a source of specific protein binding molecules. Science 1990; 249:404-406.
6. Cwirla SE, Peters EA, Barrett RW, Dower WJ. Peptides on phage: a vast library of peptides for identifying ligands. Proc Natl Acad Sci USA 1990; 87:6378-6382.
7. Kay BK, Adey NB, He YS, Manfredi JP, Mataragnon AH, Fowlkes DM. An M13 phage library displaying random 38-amino-acid peptides as a source of novel sequences with affinity to selected targets. Gene 1993; 128:59-65.
8. Robert A, Samuelson P, Andreoni C, Bachi T, Uhlen M, Binz H, Nguyen TN, Stahl S. Surface display on staphylococci: a comparative study. FEBS Lett 1996; 390:327-333.
9. Camaj P, Hirsh AE, Schmidt W, Meinke A, von Gabain A. Ligand-mediated protection against phage lysis as a positive selection strategy for the enrichment of epitopes displayed on the surface of E. coli cells. Biol Chem 2001; 382:1669-1677.
10. Etz H, Minh DB, Schellack C, Nagy E, Meinke A. Bacterial phage receptors, versatile tools for display of polypeptides on the cell surface. J Bacteriol 2001; 183:6924-6935.
11. Westerlund-Wikstrom B. Peptide display on bacterial flagella: principles and applications. Int J Med Microbiol 2000; 290:223-230.
12. Dunn IS. Total modification of the bacteriophage lambda tail tube major subunit protein with foreign peptides. Gene 1996; 183:15-21.
13. Huse WD, Sastry L, Iverson SA, Kang AS, Alting-Mees M, Burton DR, Benkovic SJ, Lerner RA. Generation of a large combinatorial library of the immunoglobulin repertoire in phage lambda. Science 1989; 246:1275-1281.
14. Sternberg N, Hoess RH. Display of peptides and proteins on the surface of bacteriophage lambda. Proc Natl Acad Sci USA 1995; 92:1609-1613.
15. Efimov VP, Nepluev IV, Mesyanzhinov VV. Bacteriophage T4 as a surface display vector. Virus Genes 1995; 10:173-177.
16. Rosenberg A, Griffin G, Studier FW, McCormick M, Berg J, Mierendorf R. T7 select phage display system: a powerful new protein display system based on bacteriophage T7. Innovations 1996; 6:1-6.
17. Ernst W, Grabherr R, Wegner D, Borth N, Grassauer A, Katinger H. Baculovirus surface display: construction and screening of a eukaryotic epitope library. Nucleic Acids Res 1998; 26:1718-1723.
18. Grabherr R, Ernst W. The baculovirus expression system as a tool for generating diversity by viral surface display. Comb Chem High Throughput Screen 2001; 4:185-192.
19. Grabherr R, Ernst W, Oker-Blom C, Jones I. Developments in the use of baculoviruses for the surface display of complex eukaryotic proteins. Trends Biotechnol 2001; 19:231-236.
20. Gates CM, Stemmer WP, Kaptein R, Schatz PJ. Affinity selective isolation of ligands from peptide libraries through display on a lac repressor "headpiece dimer". J Mol Biol 1996; 255:373-386.
21. Takahashi TT, Austin RJ, Roberts RW. mRNA display: ligand discovery, interaction analysis and beyond. Trends Biochem Sci 2003; 28:159-165.
22. Hanes J, Schaffitzel C, Knappik A, Pluckthun A. Picomolar affinity antibodies from a fully synthetic naive library selected and evolved by ribosome display. Nat Biotechnol 2000; 18:1287-1292.
23. Rodi DJ, Makowski L, Kay BK. One from column A and two from column B: the benefits of phage display in molecular-recognition studies. Curr Opin Chem Biol 2002; 6:92-96.
24. Wells JA, Lowman HB. Rapid evolution of peptide and protein binding properties in vitro. Curr Opin Biotechnol 1992; 3:355-362.
25. Lowman HB. Bacteriophage display and discovery of peptide leads for drug development. Annu Rev Biophys Biomol Struct 1997; 26:401-424.
26. Smith GP, Petrenko VA. Phage display. Chem Rev 1997; 97:391-410.
27. Webster RE. Biology of the filamentous bacteriophage. In: Kay BK, Winter J, McCafferty J, eds. Phage Display of Peptides and Proteins. San Diego: Academic Press Inc., 1996:1-20.
28. Smith GR Surface display and peptide libraries. Gene 1993; 128:1-2.
29. Greenwood J, Willis AE, Perham RN. Multiple display of foreign peptides on a filamentous bacteriophage. Peptides from Plasmodium falciparum circumsporozoite protein as antigens. J Mol Biol 1991; 220:821-827.
30. Iannolo G, Minenkova O, Petruzzelli R, Cesareni G. Modifying filamentous phage capsid: limits in the size of the major capsid protein. J Mol Biol 1995; 248:835-844.
31. Lubkowski J, Hennecke F, Pluckthun A, Wlodawer A. The structural basis of phage display elucidated by the crystal structure of the N-terminal domains of g3p. Nat Struct Biol 1998; 5:140-147.
32. Lubkowski J, Hennecke F, Pluckthun A, Wlodawer A. Filamentous phage infection: crystal structure of g3p in complex with its coreceptor, the C-terminal domain of TolA. Structure Fold Des 1999; 7:711-722.
33. Jespers LS, Messens JH, De Keyser A, Eeckhout D, Van den Brande I, Gansemans YG, Lauwereys MJ, Vlasuk GP, Stanssens PB. Surface expression and ligand-based selection of cDNAs fused to filamentous phage gene VI. Biotechnology 1995; 13:378-382.
34. Hufton SE, Moerkerk PT, Meulemans EV, de Bruine A, Arends JW, Hoogenboom HR. Phage display of cDNA repertoires: the pVI display system and its applications for the selection of immunogenic ligands. J Immunol Methods 1999; 231:39-51.
35. Roth TA, Weiss GA, Eigenbrot C, Sidhu SS. A minimized M13 coat protein defines the requirements for assembly into the bacteriophage particle. J Mol Biol 2002; 322:357-367.
36. Fuh G, Sidhu SS. Efficient phage display of polypeptides fused to the carboxyterminus of the M13 gene-3 minor coat protein. Febs Lett 2000; 480:231-234.
37. Sidhu SS. Engineering M13 for phage display. Biomol Eng 2001; 18:57-63.
38. Petrenko VA, Smith GP, Gong X, Quinn T. A library of organic landscapes on filamentous phage. Protein Eng 1996; 9:797-801.
39. Bass S, Greene R, Wells JA. Hormone phage: an enrichment method for variant proteins with altered binding properties. Proteins 1990; 8: 309-314.
40. Lowman HB, Bass SH, Simpson N, Wells JA. Selecting high-affinity binding proteins by monovalent phage display. Biochemistry 1991; 30:10832-10838.
41. Felici F, Castagnoli L, Musacchio A, Jappelli R, Cesareni G. Selection of antibody ligands from a large library of oligopeptides expressed on a multivalent exposition vector. J Mol Biol 1991; 222:301-310.
42. Breitling F, Dubel S, Seehaus T, Klewinghaus I, Little M. A surface expression vector for antibody screening. Gene 1991; 104:147-153.
43. Luzzago A, Felici F, Tramontano A, Pessi A, Cortese R. Mimicking of discontinuous epitopes by phage-displayed peptides, I. Epitope mapping of human H ferritin using a phage library of constrained peptides. Gene 1993; 128:51-57.
44. Zwick MB, Shen J, Scott JK. Homodimeric peptides displayed by the major coat protein of filamentous phage. J Mol Biol 2002; 300:307-320.
45. Wright RM, Dudas D, Gavin B, Dottavio D, Hexham JM, Lake P. A high-capacity alkaline phosphatase reporter system for the rapid analysis of specificity and relative affinity of peptides from phage-display libraries. J Immunol Methods 2001; 253:223-232.
46. Vieira J, Messing J. Production of single stranded plasmid DNA. Meth Enz 1987; 153:3-11.
47. Kramer RA, Cox F, van der Horst M, van der Oudenrijn S, Res PC, Bia J, Logtenberg T, de Kruif J. A novel helper phage that improves phage display selection efficiency by preventing the amplification of phages without recombinant protein. Nucleic Acids Res 2003; 31:e59.
48. Rondot S, Koch J, Breitling F, Dubel S. A helper phage to improve single-chain antibody presentation in phage display. Nat Biotechnol 2001; 19:75-78.
49. O'Neil KT, DeGrado WF, Mousa SA, Ramachandran N, Hoess RH. Identification of recognition sequences of adhesion molecules using phage display technology. Methods Enzymol 1994; 245:370-386.
50. Smith GP, Scott JK. Libraries of peptides and proteins displayed on filamentous phage. Methods Enzymol 1993; 217:228-257.
51. Yu J, Smith GP. Affinity maturation of phage-displayed peptide ligands. Methods Enzymol 1996; 267:3-27.
52. Sidhu SS, Lowman HB, Cunningham BC, Wells JA. Phage display for selection of novel binding peptides. Methods Enzymol 2000; 328:333-363.
53. Rodi DJ, Soares AS, Makowski L. Quantitative assessment of peptide sequence diversity in M13 combinatorial peptide phage display libraries. J Mol Biol 2002; 322:1039-1052.
54. Noren KA, Noren CJ. Construction of high-complexity combinatorial phage display peptide libraries. Methods 2001; 23:169-178.
55. Iannolo G, Minenkova O, Gonfloni S, Castagnoli L, Cesareni G. Construction, exploitation and evolution of a new peptide library displayed at high density by fusion to the major coat protein of filamentous phage. Biol Chem 1997; 378:517-521.
56. Dennis MS, Zhang M, Meng YG, Kadkhodayan M, Kirchhofer D, Combs D, Damico LA. Albumin binding as a general strategy for improving the pharmacokinetics of proteins. J Biol Chem 2002; 277:35035-35043.
57. Virnekas B, Ge L, Pluckthun A, Schneider KC, Wellnhofer G, Moroney SE. Trinucleotide phosphoramidites: ideal reagents for the synthesis of mixed oligonucleotides for random mutagenesis. Nucleic Acids Res 1994; 22: 5600-5607.
58. Larsson O, Thormeyer D, Asinger A, Wihlen B, Wahlestedt C, Liang Z. Quantitative codon optimisation of DNA libraries encoding sub-random peptides: design and characterisation of a novel library encoding transmembrane domain peptides. Nucleic Acids Res 2002; 30:e133.
59. Olofsson L, Ankarloo J, Andersson PO, Nicholls IA. Filamentous bacteriophage stability in non-aqueous media. Chem Biol 2001; 8:661-671.
60. Levitan B. Stochastic modeling and optimization of phage display. J Mol Biol 1998; 277:893-916.
61. Bonnycastle LL, Brown KL, Tang J, Scott JK. Assaying phage-bome peptides by phage capture on fibrinogen or streptavidin. Biol Chem 1997; 378:509-515.
62. Clement G, Bisoffi M, Finger AN, Wetterwald A, Thalmann GN, Cecchini MG. Peptabodies as tools to test ligands isolated from phage-displayed peptide libraries. J Immunol Methods 2003; 276:135-141.
63. Vajdos FF, Adams CW, Breece TN, Presta LG, de Vos AM, Sidhu SS. Comprehensive functional maps of the antigen-binding site of an anti-ErbB2 antibody obtained with shotgun scanning mutagenesis. J Mol Biol 2002; 320:415-428.
64. Murase K, Morrison KL, Tam PY, Stafford RL, Jurnak F, Weiss GA. EF-Tu Binding peptides identified, dissected, and affinity optimized by phage display. Chem Biol 2003; 10:161-168.
65. Weiss GA, Watanabe CK, Zhong A, Goddard A, Sidhu SS. Rapid mapping of protein functional epitopes by combinatorial alanine scanning. Proc Natl Acad Sci USA 2000; 97:8950-8954.
66. Fairbrother WJ, Christinger HW, Cochran AG, Fuh U, Keenan CJ, Quan C, Shriver SK, Tom JY, Wells JA, Cunningham BC. Novel peptides selected to bind vascular endothelial growth factor target the receptor-binding site. Biochemistry 1998; 37:17754-17764.
67. Collins I, Horn N, Wadenback J, Szardenings M. Cosmix-plexing: a novel recombinatorial approach for evolutionary selection from combinatorial libraries. J Biotechnol 2001; 74:317-338.
68. Luo GX, Victor K, Chong K, McNeeley P, Ramirez D, Preclaro J, Linnik MD, Campbell MA. Identification of a peptide that protects the human acetylcholine receptor against antigenic modulation. J Immunol Methods 2001; 251:177-186.
69. Hoess R, Brinkmann U, Handel T, Pastan I. Identification of a peptide which binds to the carbohydrate-specific monoclonal antibody B3. Gene 1993; 128:43-49.
70. Qiu JX, Marcus DM. Use of peptide ligands to analyze the fine specificity of antibodies against asialo GMI. J Neuroimmunol 1999; 100:58-63.
71. Kola A, Baensch M, Bautsch W, Hennecke M, Klos A, Casaretto M, Kohl J. Epitope mapping of a C5a neutralizing mAb using a combined approach of phage display, synthetic peptides and site-directed mutagenesis. Immunotechnology 1996; 2:115-126.
72. McConnell SJ, Kendall ML, Reilly TM, Hoess RH. Constrained peptide libraries as a tool for finding mimotopes. Gene 1994; 151:115-118.
73. Miceli RM, DeGraaf ME, Fischer HD. Two-stage selection of sequences from a random phage display library delineates both core residues and permitted structural range within an epitope. J Immunol Methods 1994; 167:279-287.
74. D'Mello F, Partidos CD, Steward MW, Howard CR. Definition of the primary structure of hepatitis B virus (HBV) pre-S hepatocyte binding domain using random peptide libraries. Virology 1997; 237:319-326.
75. Rudolf MP, Vogel M, Kricek F, Ruf C, Zurcher AW, Reuschel R, Auer M, Miescher S, Stadler BM. Epitope-specific antibody response to IgE by mimotope immunization. J Immunol 1998; 160:3315-3321.
76. Moshitch-Moshkovitz S, Heldman Y, Yayon A, Katchalski-Katzir E. Sorting polyclonal antibodies into functionally distinct fractions using peptide phage display: 'a library on top of a library'. J Immunol Methods 2000; 242:183-191.
77. Roberts D, Guegler K, Winter J. Antibody as a surrogate receptor in the screening of a phage display library. Gene 1993; 128:67-69.
78. Dybwad A, Lambin P, Sioud M, Zouali M. Probing the specificity of human myeloma proteins with a random peptide phage library. Scand J Immunol 2003; 57:583-590.
79. Folgori A, Tafi R, Meola A, Felici F, Galfre G, Cortese R, Monaci P, Nicosia A. A general strategy to identify mimotopes of pathological antigens using only random peptide libraries and human sera. Embo J 1994; 13:2236-2243.
80. Mintz PJ, Kim J, Do KA, Wang X, Zinner RG, Cristofanilli M, Arap MA, Hong WK, Troncoso P, Logothetis CJ, Pasqualini R, Arap W. Fingerprinting the circulating repertoire of antibodies from cancer patients. Nat Biotechnol 2003; 21:57-63.
81. Rey E, Zeidel M, Rhine C, Tami J, Krolick K, Fischbach M, Sanz I. Characterization of human anti-acetylcholine receptor monoclonal autoantibodies from the peripheral blood of a myasthenia gravis patient using combinatorial libraries. Clin Immunol 2000; 96:269-279.
82. Hyde-DeRuyscher R, Paige LA, Christensen DJ, Hyde-DeRuyscher N, Lim A, Fredericks ZL, Kranz J, Gallant P, Zhang J, Rocklage SM, Fowlkes DM, Wendler PA, Hamilton PT. Detection of small-molecule enzyme inhibitors with peptides isolated from phage-displayed combinatorial peptide libraries. Chem Biol 2000; 7:17-25.
83. Krook M, Lindbladh C, Birnbaum S, Naess H, Eriksen JA, Mosbach K. Selection of peptides with surface affinity for α-chymotrypsin using a phage display library. J Chromatogr A 1995; 711:119-128.
84. Huang L, Sexton DJ, Skogerson K, Devlin M, Smith R, Sanyal I, Parry T, Kent R, Enright J, Wu QL, Conley G, DeOliveira D, Morganelli L, Ducar M, Wescott CR, Ladner RC. Novel peptide inhibitors of angiotensin-converting enzyme 2. J Biol Chem 2003; 278:15532-15540.
85. Maun HR, Eigenbrot C, Lazarus RA. Engineering exosite peptides for complete inhibition of factor VIIa using a protease switch with substrate phage. J Biol Chem 2003; 278:21823-21830.
86. Koivunen B, Arap W, Valtanen H, Rainisalo A, Medina OP, Heikkila P, Kantor C, Gahmberg CG, Salo T, Konttinen YT, Sorsa T, Ruoslahti E, Pasqualini R. Tumor targeting with a selective gelatinase inhibitor. Nat Biotechnol 1999; 17:768-774.
87. Smith GP, Schultz DA, Ladbury JE. A ribonuclease S-peptide antagonist discovered with a bacteriophage display library. Gene 1993; 128:37-42.
88. Nishi T, Budde RJ, McMurray JS, Obeyesekere NU, Safdar N, Levin VA, Saya H. Tight-binding inhibitory sequences against pp60(c-src) identified using a random 15-amino-acid peptide library. Febs Lett 1996; 399:237-240.
89. Houimel M, Mach JP, Corthesy-Theulaz I, Corthesy B, Fisch I. New inhibitors of Helicobacter pylori urease holoenzyme selected from phage-displayed peptide libraries. Eur J Biochem 1999; 262:774-780.
90. Huang C, De Sanctis GT, O'Brien PJ, Mizgerd JP, Friend DS, Drazen JM, Brass LF, Stevens RL. Evaluation of the substrate specificity of human mast cell tryptase_I and demonstration of its importance in bacterial infections of the lung. J Biol Chem 2001; 276:26276-26284.
91. Smith MM, Shi L, Navre M. Rapid identification of highly active and selective substrates for stromelysin and matrilysin using bacteriophage peptide display libraries. J Biol Chem 1995; 270:6440-6449.
92. Matthews DJ, Wells JA. Substrate phage: selection of protease substrates by monovalent phage display. Science 1993; 260:1113-1117.
93. Huang C, Wong GW, Ghildyal N, Gurish MF, Sali A, Matsumoto R, Qiu WT, Stevens RL. The tryptase, mouse mast cell protease 7, exhibits anticoagulant activity in vivo and in vitro due to its ability to degrade fibrinogen in the presence of the diverse array of protease inhibitors in plasma. J Biol Chem 1997; 272: 31885-31893.
94. Schmitz R, Baumann G, Gram H. Catalytic specificity of phosphotyrosine kinases Blk, Lyn, c-Src and Syk as assessed by phage display. J Mol Biol 1996; 260:664-677.
95. Arap W, Kolonin MG, Trepel M, Lahdenranta J, Cardo-Vila M, Giordano RJ, Mintz PJ, Ardelt PU, Yao VJ, Vidal CI, Chen L, Flamm A, Valtanen H, Weavind LM, Hicks ME, Pollock RE, Botz GH, Bucana CD, Koivunen E, Cahill D, Troncoso P, Baggerly KA, Pentz RD, Do KA, Logothetis CJ, Pasqualini R. Steps toward mapping the human vasculature by phage display. Nat Med 2002; 8:121-127.
96. Houston P, Goodman J, Lewis A, Campbell CJ, Braddock M. Homing markers for atherosclerosis: applications for drug delivery, gene delivery and vascular imaging. FEBS Lett 2001; 492:73-77.
97. Romanov VI, Durand DB, Petrenko VA. Phage display selection of peptides that affect prostate carcinoma cells attachment and invasion. Prostate 2001; 47:239-251.
98. Pasqualini R, Koivunen E, Kain R, Lahdenranta J, Sakamoto M, Stryhn A, Ashmun RA, Shapiro LH, Arap W, Ruoslahti E. Aminopeptidase N is a receptor for tumor-homing peptides and a target for inhibiting angiogenesis. Cancer Res 2000; 60:722-727.
99. Rajotte D, Ruoslahti E. Membrane dipeptidase is the receptor for a lung-targeting peptide identified by in vivo phage display. J Biol Chem 1999; 274:11593-11598.
100. Larocca D, Witte A, Johnson W, Pierce GF, Baird A. Targeting bacteriophage to mammalian cell surface receptors for gene delivery. Hum Gene Ther 1998; 9:2393-2399.
101. Larocca D, Kassner PD, Witte A, Ladner RC, Pierce GF, Baird A. Gene transfer to mammalian cells using genetically targeted filamentous bacteriophage. FASEB J 1999; 13:727-734.
102. Michon IN, Hauer AD, von der Thusen JH, Molenaar TJ, van Berkel TJ, Biessen EA, Kuiper J. Targeting of peptides to restenotic vascular smooth muscle cells using phage display in vitro and in vivo. Biochim Biophys Acta 2002; 1591:87-97.
103. Ivanenkov VV, Felici F, Menon AG. Targeted delivery of multivalent phage display vectors into mammalian cells. Biochim Biophys Acta 1999; 1448:463-472.
104. Work LM, Nicklin SA, White SJ, Baker AH. Use of phage display to identify novel peptides for targeted gene therapy. Methods Enzymol 2002; 346:157-176.
105. Kolonin M, Pasqualini R, Arap W. Molecular addresses in blood vessels as targets for therapy. Curr Opin Chem Biol 2001; 5:308-313.
106. Trepel M, Arap W, Pasqualini R. In vivo phage display and vascular heterogeneity: implications for targeted medicine. Curr Opin Chem Biol 2002; 6:399-404.
107. Pasqualini R, Arap W, McDonald DM. Probing the structural and molecular diversity of tumor vasculature. Trends Mol Med 2002; 8:563-571.
108. Larocca D, Burg MA, Jensen-Pergakes K, Ravey EP, Gonzalez AM, Baird A. Evolving phage vectors for cell targeted gene delivery. Curr Pharm Biotechnol 2002; 3:45-57.
109. Hsu CL, Yeh S, Chen YL, Ting HJ, Hu YC, Lin H, Wang X, Chang C. The use of phage display technique for the isolation of androgen receptor interacting peptides with F/WXXLF/W and FXXLY new signature motifs. J Biol Chem 2003; 2003:24.
110. Chang C, Norris JD, Gron H, Paige LA, Hamilton PT, Kenan DJ, Fowlkes D, McDonnell DP. Dissection of the LXXLL nuclear receptor-coactivator interaction motif using combinatorial peptide libraries: discovery of peptide antagonists of estrogen receptors α and β. Mol Cell Biol 1999; 19:8226-8239.
111. Hall JM, Chang CY, McDonnell DP. Development of peptide antagonists that target estrogen receptor β-coactivator interactions. Mol Endocrinol 2000; 14:2010-2023.
112. Venkatesh N, Zaltsman Y, Somjen D, Gayer B, Boopathi E, Kasher R, Kulik T, Katchalski-Katzir E, Kohen F. A synthetic peptide with estrogen-like activity derived from a phage-display peptide library. Peptides 2002; 23:573-580.
113. Giangrande PH, Kimbrel EA, Edwards DP, McDonnell DP. The opposing transcriptional activities of the two isoforms of the human progesterone receptor are due to differential cofactor binding. Mol Cell Biol 2000; 20:3102-3115.
114. Dubree NJ, Artis DR, Castanedo G, Marsters J, Sutherlin D, Caris L, Clark K, Keating SM, Beresini MH, Chiu H, Fong S, Lowman HB, Skelton NJ, Jackson DY. Selective_4_7 integrin antagonists and their potential as anti-inflammatory agents. J Med Chem 2002; 45:3451-3457.
115. Koivunen E, Gay DA, Ruoslahti E. Selection of peptides binding to the α5β1 integrin from phage display library. J Biol Chem 1993; 268:20205-20210.
116. Koivunen E, Wang B, Ruoslahti E. Isolation of a highly specific ligand for the α5β1 integrin from a phage display library. J Cell Biol 1994; 124:373-380.
117. Murayama O, Nishida H, Sekiguchi K. Novel peptide ligands for integrin α6β1 selected from a phage display library. J Biochem 1996; 120:445-451.
118. Healy JM, Murayama O, Maeda T, Yoshino K, Sekiguchi K, Kikuchi M. Peptide ligands for integrin αvβ3 selected from random phage display libraries. Biochemistry 1995; 34:3948-3955.
119. Kraft S, Diefenbach B, Mehta R, Jonczyk A, Luckenbach GA, Goodman SL. Definition of an unexpected ligand recognition motif for αvβ6 integrin. J Biol Chem 1999; 274:1979-1985.
120. Rao WH, Camp RD. Novel cyclic and linear oligopeptides that bind to integrin β1 chain and either inhibit or costimulate T lymphocytes. Int Immunopharmacol 2003; 3:435-443.
121. Couet J, Li S, Okamoto T, Ikezu T, Lisanti MP. Identification of peptide and protein ligands for the caveolin-scaffolding domain. Implications for the interaction of caveolin with caveolae-associated proteins. J Biol Chem 1997; 272:6525-6533.
122. Houimel M, Loetscher P, Baggiolini M, Mazzucchelli L. Functional inhibition of CCR3-dependent responses by peptides derived from phage libraries. Eur J Immunol 2001; 31:3535-3545.
123. Richards JL, Abend JR, Miller ML, Chakraborty-Sett S, Dewhurst S, Whetter LE. A peptide containing a novel FPGN CD40-binding sequence enhances adenoviral infection of murine and human dendritic cells. Eur J Biochem 2003; 270:2287-2294.
124. Fukumoto T, Torigoe N, Kawabata S, Murakami M, Uede T, Nishi T, Ito Y, Sugimura K. Peptide mimics of the CTLA4-binding domain stimulate T-cell proliferation. Nat Biotechnol 1998; 16:267-270.
125. Martens CL, Cwirla SE, Lee RY, Whitehorn E, Chen EY, Bakker A, Martin EL, Wagstrom C, Gopalan P, Smith CW, Tate E, Koller KJ, Schatz PJ, Dower WJ, Barrett RW. Peptides which bind to E-selectin and block neutrophil adhesion. J Biol Chem 1995; 270:21129-21136.
126. Pasqualini R, Koivunen E, Ruoslahti B. A peptide isolated from phage display libraries is a structural and functional mimic of an RGD-binding site on integrins. J Cell Biol 1995; 130:1189-1196.
127. Eckert DM, Malashkevich VN, Hong LH, Carr PA, Kim PS. Inhibiting HIV-1 entry: discovery of D-peptide inhibitors that target the gp41 coiled-coil pocket. Cell 1999; 99:103-115.
128. Ferrer M, Harrison SC. Peptide ligands to human immunodeficiency virus type 1 gp120 identified from phage display libraries. J Virol 1999; 73:5795-5802.
129. Xia H, Anderson B, Mao Q, Davidson BL. Recombinant human adenovirus: targeting to the human transferrin receptor improves gene transfer to brain microcapillary endothelium. J Virol 2000; 74:11359-11366.
130. Vanhoorelbeke K, Depraetere H, Romijn RA, Huizinga EG, De Maeyer M, Deckmyn H. A consensus tetra-peptide selected by phage display adopts the conformation of a dominant discontinuous epitope of a monoclonal anti-VWF antibody that inhibits the VWF-collagen interaction. J Biol Chem 2003; 2003:10.
131. Feng Y, Chung D, Garrard L, McEnroe G, Lim D, Scardina J, McFadden K, Guzzetta A, Lam A, Abraham J, Liu D, Endemann G. Peptides derived from the complementarity-determining regions of anti-Mac-1 antibodies block intercellular adhesion molecule-1 interaction with Mac-1. J Biol Chem 1998; 273:5625-5630.
132. Kaji M, Ikari M, Hashiguchi S, Ito Y, Matsumoto R, Yoshimura T, Kuratsu J, Sugimura K. Peptide mimics of monocyte chemoattractant protein-1 (MCP-1) with an antagonistic activity. J Biochem 2001; 129:577-583.
133. O'Neil KT, Hoess RH, Jackson SA, Ramachandran NS, Mousa SA, DeGrado WF. Identification of novel peptide antagonists for GPIIb/IIIa from a conformationally constrained phage peptide library. Proteins 1992; 14:509-515.
134. Molenaar TJ, Appeldoorn CC, de Haas SA, Michon IN, Bonnefoy A, Hoylaerts MF, Pannekoek H, van Berkel TJ, Kuiper J, Biessen EA. Specific inhibition of P-selectin-mediated cell adhesion by phage display-derived peptide antagonists. Blood 2002; 100:3570-3577.
135. Dmitriev IP, Kashentseva EA, Curiel DT. Engineering of adenovirus vectors containing heterologous peptide sequences in the C terminus of capsid protein IX. J Virol 2002; 76:6893-6899.
136. Campa MJ, Serlin SB, Patz E Jr. Development of novel tumor imaging agents with phage-display combinatorial peptide libraries. Acad Radiol 2002; 9:927-932.
137. Koolpe M, Dail M, Pasquale EB. An ephrin mimetic peptide that selectively targets the EphA2 receptor. J Biol Chem 2002; 277:46974-46979.
138. Karasseva NG, Glinsky VV, Chen NX, Komatireddy R, Quinn TP. Identification and characterization of peptides that bind human ErbB-2 selected from a bacteriophage display library. J Protein Chem 2002; 21:287-296.
139. Wrighton NC, Farrell FX, Chang R, Kashyap AK, Barbone FP, Mulcahy LS, Johnson DL, Barrett RW, Jolliffe LK, Dower WJ. Small peptides as potent mimetics of the protein hormone erythropoietin. Science 1996; 273:458-464.
140. Johnson DL, Farrell FX, Barbone FP, McMahon FJ, Tullai J, Hoey K, Livnah O, Wrighton NC, Middleton SA, Loughney DA, Stura EA, Dower WJ, Mulcahy LS, Wilson IA, Jolliffe LK. Identification of a 13 amino acid peptide mimetic of erythropoietin and description of amino acids critical for the mimetic activity of EMP1. Biochemistry 1998; 37:3699-3710.
141. Skelton NJ, Russell S, de Sauvage F, Cochran AG. Amino acid determinants of β-hairpin conformation in erythropoeitin receptor agonist peptides derived from a phage display library. J Mol Biol 2002; 316:1111-1125.
142. McConnell SJ, Dinh T, Le MH, Brown SJ, Becherer K, Blumeyer K, Kautzer C, Axelrod F, Spinella DG. Isolation of erythropoietin receptor agonist peptides using evolved phage libraries. Biol Chem 1998; 379:1279-1286.
143. Ballinger MD, Shyamala V, Forrest LD, Deuter-Reinhard M, Doyle LV, Wang JX, Panganiban-Lustan L, Stratton JR, Apell G, Winter JA, Doyle MV, Rosenberg S, Kavanaugh WM. Semirational design of a potent, artificial agonist of fibroblast growth factor receptors. Nat Biotechnol 1999; 17:1199-1204.
144. Deshayes K, Schaffer ML, Skelton NJ, Nakamura GR, Kadkhodayan S, Sidhu SS. Rapid identification of small binding motifs with high-throughput phage display: discovery of peptidic antagonists of IGF-1 function. Chem Biol 2002; 9:495-505.
145. Lowman HB, Chen YM, Skelton NJ, Mortensen DL, Tomlinson EE, Sadick MD, Robinson IC, Clark RG. Molecular mimics of insulin-like growth factor 1 (IGF-1) for inhibiting IGF-1: IGF-binding protein interactions. Biochemistry 1998; 37:8870-8878.
146. Renschler ME, Bhatt RR, Dower WJ, Levy R. Synthetic peptide ligands of the antigen binding receptor induce programmed cell death in a human B-cell lymphoma. Proc Natl Acad Sci USA 1994; 91:3623-3627.
147. Pillutla RC, Hsiao KC, Beasley JR, Brandt J, Ostergaard S, Hansen PH, Spetzler JC, Danielsen GM, Andersen AS, Brissette RE, Lennick M, Fletcher PW, Blume AJ, Schaffer L, Goldstein NI. Peptides identify the critical hotspots involved in the biological activation of the insulin receptor. J Biol Chem 2002; 277:22590-22594.
148. Sato A, Sone S. A peptide mimetic of human interferon (IFN)-β. Biochem J 2003; 371:603-608.
149. Yanofsky SD, Baldwin DN, Butler JH, Holden FR, Jacobs JW, Balasubramanian P, Chinn JP, Cwirla SE, Peters-Bhatt E, Whitehorn EA, Tate EH, Akeson A, Bowlin TL, Dower WJ, Barrett RW. High affinity type 1 interleukin 1 receptor antagonists discovered by screening recombinant peptide libraries. Proc Natl Acad Sci USA 1996; 93:7381-7386.
150. Akeson AL, Woods CW, Hsieh LC, Bohnke RA, Ackermann BL, Chan KY, Robinson JL, Yanofsky SD, Jacobs JW, Barrett RW, Bowlin TL. AF12198, a novel low molecular weight antagonist, selectively binds the human type 1 interleukin (IL)-1 receptor and blocks in vivo responses to IL-1. J Biol Chem 1996; 271:30517-30523.
151. England BP, Balasubramanian P, Uings I, Bethell S, Chen MJ, Schatz PJ, Yin Q, Chen YF, Whitehorn EA, Tsavaler A, Martens CL, Barrett RW, McKinnon M. A potent dimeric peptide antagonist of interleukin-5 that binds two interleukin-5 receptor β chains. Proc Natl Acad Sci USA 2000; 97:6862-6867.
152. Szardenings M, Tornroth S, Mutulis F, Muceniece R, Keinanen K, Kuusinen A, Wikberg JE. Phage display selection on whole cells yields a peptide specific for melanocortin receptor 1. J Biol Chem 1997; 272:27943-27948.
153. Szardenings M, Muceniece R, Mutule I, Mutulis F, Wikberg JE. New highly specific agonistic peptides for human melanocortin MC(1) receptor. Peptides 2000; 21:239-243.
154. Wright RM, Gram H, Vattay A, Byme S, Lake P, Dottavio D. Binding epitope of somatostatin defined by phage-displayed peptide libraries. Biotechnology 1995; 13:165-169.
155. Michon IN, Penning LC, Molenaar TJ, van Berkel TJ, Biessen EA, Kuiper J. The effect of TGF-α receptor binding peptides on smooth muscle cells. Biochem Biophys Res Commun 2002; 293:1279-1286.
156. Doorbar J, Winter G. Isolation of a peptide antagonist to the thrombin receptor using phage display. J Mol Biol 1994; 244:361-369.
157. Cwirla SE, Balasubramanian P, Duffin DJ, Wagstrom CR, Gates CM, Singer SC, Davis AM, Tansik RL, Mattheakis LC, Boytos CM, Schatz PJ, Baccanari DP, Wrighton NC, Barrett RW, Dower WJ. Peptide agonist of the thrombopoietin receptor as potent as the natural cytokine. Science 1997; 276:1696-1699.
158. Hsiao KC, Brissette RE, Wang P, Fletcher PW, Rodriguez V, Lennick M, Blume AJ, Goldstein NI. Peptides identify multiple hotspots within the ligand binding domain of the TNF receptor 2. Proteome Sci 2003; 1:1.
159. Sato A, Ida N, Fukuyama M, Miwa K, Kazami J, Nakamura H. Identification from a phage display library of peptides that bind to toxic shock syndrome toxin-1 and that inhibit its binding to major histocompatibility complex (MHC) class II molecules. Biochemistry 1996; 35:10441-10447.
160. Goodson RJ, Doyle MV, Kaufman SE, Rosenberg S. High-affinity urokinase receptor antagonists identified with bacteriophage peptide display. Proc Natl Acad Sci USA 1994; 91:7129-7133.
161. Wiesmann C, Christinger HW, Cochran AG, Cunningham BC, Fairbrother WJ, Keenan CJ, Meng G, de Vos AM. Crystal structure of the complex between VEGF and a receptor-blocking peptide. Biochemistry 1998; 37:17765-17772.
162. Binetruy-Tournaire R, Demangel C, Malavaud B, Vassy R, Rouyre S, Kraemer M, Plouet J, Derbin C, Perret G, Mazie JC. Identification of a peptide blocking vascular endothelial growth factor (VEGF)-mediated angiogenesis. EMBO J 2000; 19:1525-1533.
163. Hetian L, Ping A, Shumei S, Xiaoying L, Luowen H, Jian W, Lin M, Meisheng L, Junshan Y, Chengchao S. A novel peptide isolated from a phage display library inhibits tumor growth and metastasis by blocking the binding of vascular endothelial growth factor to its kinase domain receptor. J Biol Chem 2002; 277:43137-43142.
164. Livnah O, Johnson DL, Stura EA, Farrell FX, Barbone FP, You Y, Liu KD, Goldsmith MA, He W, Krause CD, Pestka S, Jolliffe LK, Wilson IA. An antagonist peptide-EPO receptor complex suggests that receptor dimerization is not
165. Syed RS, Reid SW, Li C, Cheetham JC, Aoki KU, Liu B, Zhan H, Osslund TD, Chirino AJ, Zhang J, Finer-Moore J, Elliott S, Sitney K, Katz BA, Matthews DJ, Wendoloski JJ, Egrie J, Stroud RM. Efficiency of signalling through cytokine receptors depends critically on receptor orientation. Nature 1998; 395:511-516.
166. Mirzabekov T, Kontos H, Farzan M, Marasco W, Sodroski J. Paramagnetic proteoliposomes containing a pure, native, and oriented seven-transmembrane segment protein, CCR5. Nat Biotechnol 2000; 18:649-654.
167. Bremnes T, Lauvrak V, Lindqvist B, Bakke O. Selection of phage displayed peptides from a random 10-mer library recognising a peptide target. Immunotechnology 1998; 4:21-28.
168. Linn H, Ermekova KS, Rentschler S, Sparks AB, Kay BK, Sudol M. Using molecular repertoires to identify high-affinity peptide ligands of the WW domain of human and mouse YAP. Biol Chem 1997; 378:531-537.
169. Krook M, Mosbach K, Lindbladh C. Selection of peptides with affinity for single stranded DNA using a phage display library. Biochem Biophys Res Commun 1994; 204:849-854.
170. Turnbough C Jr. Discovery of phage display peptide ligands for species-specific detection of Bacillus spores. J Microbiol Methods 2003; 53:263-271.
171. Petrenko VA, Vodyanoy VJ. Phage display for detection of biological threat agents. J Microbiol Methods 2003; 53:253-262.
172. Kazmin DA, Hoyt TR, Taubner L, Teintze M, Starkey JR. Phage display mapping for peptide 11 sensitive sequences binding to laminin-1. J Mol Biol 2000; 298:431-445.
173. Kragler F, Monzer J, Xoconostle-Cazares B, Lucas WJ. Peptide antagonists of the plasmodesmal macromolecular trafficking pathway. EMBO J 2000; 19:2856-2868.
174. Linse S, Hardig Y, Schultz DA, Dahlback B. A region of vitamin K-dependent protein S that binds to C4b binding protein (C4BP) identified using bacteriophage peptide display libraries. J Biol Chem 1997; 272:14658-14665.
175. Sauk JJ, Coletta RD, Norris K, Hebert C. Binding motifs of CBP2 a potential cell surface target for carcinoma cells. J Cell Biochem 2000; 78:251-263.
176. Cheadle C, Ivashchenko Y, South V, Searfoss GH, French S, Howk R, Ricca GA, Jaye M. Identification of a Src SH3 domain binding motif by screening a random phage display library. J Biol Chem 1994; 269:24034-24039.
177. Sparks AB, Quilliam LA, Thorn JM, Der CJ, Kay BK. Identification and characterization of Src SH3 ligands from phage-displayed random peptide libraries. J Biol Chem 1994; 269:23853-23856.
178. Rickles RJ, Botfield MC, Zhou XM, Henry PA, Brugge JS, Zoller MJ. Phage display selection of ligand residues important for Src homology 3 domain binding specificity. Proc Natl Acad Sci USA 1995; 92:10909-10913.
179. Fazi B, Cope MJ, Douangamath A, Ferracuti S, Schirwitz K, Zucconi A, Drubin DG, Wilmanns M, Cesareni G, Castagnoli L. Unusual binding properties of the SH3 domain of the yeast actin-binding protein Abp 1: structural and functional analysis. J Biol Chem 2002; 277:5290-5298.
180. Sparks AB, Rider JE, Hoffman NG, Fowlkes DM, Quillam LA, Kay BK. Distinct ligand preferences of Src homology 3 domains from Src, Yes, Abl, Cortactin, p53bp2, PLCβ, Crk, and Grb2. Proc Natl Acad Sci USA 1996; 93:1540-1544.
181. Rickles RJ, Botfield MC, Weng Z, Taylor JA, Green OM, Brugge JS, Zoller MJ. Identification of Src, Fyn, Lyn, PI3K and Abl SH3 domain ligands using phage display libraries. EMBO J 1994; 13:5598-5604.
182. Feng S, Kasahara C, Rickles RJ, Schreiber SL. Specific interactions outside the proline-rich core of two classes of Src homology 3 ligands. Proc Natl Acad Sci USA 1995; 92:12408-12415.
183. Bunnell SC, Henry PA, Kolluri R, Kirchhausen T, Rickles RJ, Berg LJ. Identification of Itk/Tsk Src homology 3 domain ligands. J Biol Chem 1996; 271:25646-25656.
184. Mongiovi AM, Romano PR, Panni S, Mendoza M, Wong WT, Musacchio A, Cesareni G, Di Fiore PP. A novel peptide-SH3 interaction. Embo J 1999; 18:5300-5309.
185. Schumacher TN, Mayr LM, Minor D Jr., Milhollen MA, Burgess MW, Kim PS. Identification of D-peptide ligands through mirror-image phage display. Science 1996; 271:1854-1857.
186. Pisabarro MT, Serrano L. Rational design of specific high-affinity peptide ligands for the Abl-SH3 domain. Biochemistry 1996; 35:10540-10634.
187. Balass M, Katchalski-Katzir E, Fuchs S. The α-bungarotoxin binding site on the nicotinic acetylcholine receptor: analysis using a phage-epitope library. Proc Natl Acad Sci USA 1997; 94:6054-6058.
188. Scherf T, Kasher R, Balass M, Fridkin M, Fuchs S, Katchalski-Katzir B. A β-hairpin structure in a 13-mer peptide that binds α-bungarotoxin with high affinity and neutralizes its toxicity. Proc Natl Acad Sci USA 2001; 98:6629-6634.
189. Kasher R, Balass M, Scherf T, Fridkin M, Fuchs S, Katchalski-Katzir E. Design and synthesis of peptides that bind α-bungarotoxin with high affinity. Chem Biol 2001; 8:147-155.
190. Dedman JR, Kaetzel MA, Chan UC, Nelson DJ, Jamieson G Jr. Selection of targeted biological modifiers from a bacteriophage library of random peptides. The identification of novel calmodulin regulatory peptides. J Biol Chem 1993; 268:23025-23030.
191. Adey NB, Kay BK. Identification of calmodulin-binding peptide consensus sequences from a phage-displayed random peptide library. Gene 1996; 169:133-134.
192. Sahu A, Kay BK, Lambris JD. Inhibition of human complement by a C3-binding peptide isolated from a phage-displayed random peptide library. J Immunol 1996; 157:884-891.
193. Oldenburg KR, Loganathan D, Goldstein IJ, Schultz PG, Gallop MA. Peptide ligands for a sugar-binding protein isolated from a random peptide library. Proc Natl Acad Sci USA 1992; 89:5393-5397.
194. Scott JK, Loganathan D, Easley RB, Gong X, Goldstein IJ. A family of concanavalin A-binding peptides from a hexapeptide epitope library. Proc Natl Acad Sci USA 1992; 89:5398-5402.
195. Ehrlich GK, Bailon P. Identification of model peptides as affinity ligands for the purification of humanized monoclonal antibodies by means of phage display. J Biochem Biophys Methods 2001; 49:443-454.
196. Hessling J, Lohse MJ, Klotz KN. Peptide G protein agonists from a phage display library. Biochem Pharmacol 2003; 65:961-967.
197. Ide T, Baik SH, Matsuba T, Harayama S. Identification by the phage-display technique of peptides that bind to H7 flagellin of Escherichia coli. Biosci Biotechnol Biochem 2003; 67:1335-1341.
198. Dyson MR, Murray K. Selection of peptide inhibitors of interactions involved in complex protein assemblies: association of the core and surface antigens of hepatitis B virus. Proc Natl Acad Sci USA 1995; 92:2194-2198.
199. Franklin MC, Kadkhodayan S, Ackerly H, Alexandru D, Distefano MD, Elliott LO, Flygare JA, Mausisa G, Okawa DC, Ong D, Vucic D, Deshayes K, Fairbrother WJ. Structure and function analysis of peptide antagonists of melanoma inhibitor of apoptosis (ML-IAP). Biochemistry 2003; 42:8223-8231.
200. Mourez M, Kane RS, Mogridge J, Metallo S, Deschatelets P. Sellman BR, Whitesides GM, Collier RJ. Designing a polyvalent inhibitor of anthrax toxin. Nat Biotechnol 2001; 19:958-961.
201. Sato AK, Sexton DJ, Morganelli LA, Cohen EH, Wu QL, Conley GP, Streltsova Z, Lee SW, Devlin M, DeOliveira DB, Enright J, Kent RB, Wescott CR, Ransohoff TC, Ley AC, Ladner RC. Development of mammalian serum albumin affinity purification media by peptide phage display. Biotechnol Prog 2002; 18:182-192.
202. Adey NB, Kay BK. Isolation of peptides from phage-displayed random peptide libraries that interact with the talin-binding domain of vinculin. Biochem J 1997; 324:523-528.
203. D'Mello F, Howard CR. An improved selection procedure for the screening of phage display peptide libraries. J Immunol Methods 2001; 247:191-203.
204. Petrenko VA, Smith OP. Phages from landscape libraries as substitute antibodies. Protein Eng 2000; 13:589-592.
205. Halperin I, Wolfson H, Nussinov R. SiteLight: binding-site prediction using phage display libraries. Protein Sci 2003; 12:1344-1359.
206. Kozlov IA, Mao S, Xu Y, Huang X, Lee L, Sears PS, Gao C, Coyle AR, Janda KD, Wong CH. Synthesis of solid-supported mirror-image sugars: a novel method for selecting receptors for cellular-surface carbohydrates. Chembiochem 2001; 2:741-746.
207. Aina OH, Sroka TC, Chen ML, Lam KS. Therapeutic cancer targeting peptides. Biopolymers 2002; 66:184-199.
208. Goldberg M, Gomez-Orellana I. Challenges for the oral delivery of macromolecules. Nat Rev Drug Discov 2003; 2:289-295.
209. Gratton JP, Yu J, Griffith JW, Babbitt RW, Scotland RS, Hickey R, Giordano FJ, Sessa WC. Cell-permeable peptides improve cellular uptake and therapeutic gene delivery of replication-deficient viruses in cells and in vivo. Nat Med 2003; 9:357-362.
210. Torchilin VP, Lukyanov AN. Peptide and protein drug delivery to and into tumors: challenges and solutions. Drug Discov Today 2003; 8:259-266.
211. Bray BL. Large-scale manufacture of peptide therapeutics by chemical synthesis. Nat Rev Drug Discov 2003; 2:587-593.
212. Eckert DM, Kim PS. Design of potent inhibitors of HIV-1 entry from the gp41 N-peptide region. Proc Natl Acad Sci USA 2001; 98:11187-11192.